Lilly Settles Cialis Generic Patent Suit, Cuts Exclusivity
Eli Lilly and Company reached a settlement in Virginia federal court with generic drug companies accused of infringing its unit-dose patent for its sexual dysfunction treatment Cialis, maintaining its market exclusivity...To view the full article, register now.
Already a subscriber? Click here to view full article